These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 17045310)
1. In vitro and in vivo effect of BU99006 (5-isothiocyanato-2-benzofuranyl-2-imidazoline) on I2 binding in relation to MAO: evidence for two distinct I2 binding sites. Paterson LM; Tyacke RJ; Robinson ES; Nutt DJ; Hudson AL Neuropharmacology; 2007 Feb; 52(2):395-404. PubMed ID: 17045310 [TBL] [Abstract][Full Text] [Related]
2. 5-Isothiocyanato-2-benzofuranyl-2-imidazoline (BU99006) an irreversible imidazoline(2) binding site ligand: in vitro and in vivo characterisation in rat brain. Tyacke RJ; Robinson ES; Nutt DJ; Hudson AL Neuropharmacology; 2002 Jul; 43(1):75-83. PubMed ID: 12213261 [TBL] [Abstract][Full Text] [Related]
3. The imidazoline I2-site ligands BU 224 and 2-BFI inhibit MAO-A and MAO-B activities, hydrogen peroxide production, and lipolysis in rodent and human adipocytes. Bour S; Iglesias-Osma MC; Marti L; Duro P; Garcia-Barrado MJ; Pastor MF; Prévot D; Visentin V; Valet P; Moratinos J; Carpéné C Eur J Pharmacol; 2006 Dec; 552(1-3):20-30. PubMed ID: 17056035 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver. Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546 [TBL] [Abstract][Full Text] [Related]
5. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain. Miralles A; Esteban S; Sastre-Coll A; Moranta D; Asensio VJ; García-Sevilla JA Eur J Pharmacol; 2005 Aug; 518(2-3):234-42. PubMed ID: 16061219 [TBL] [Abstract][Full Text] [Related]
6. Characterisation of imidazoline I2 binding sites in pig brain. Anderson NJ; Lupo PA; Nutt DJ; Hudson AL; Robinson ES Eur J Pharmacol; 2005 Sep; 519(1-2):68-74. PubMed ID: 16109401 [TBL] [Abstract][Full Text] [Related]
7. In vivo estimation of imidazoline(2) binding site turnover. Paterson LM; Robinson ES; Nutt DJ; Hudson AL Ann N Y Acad Sci; 2003 Dec; 1009():367-70. PubMed ID: 15028614 [TBL] [Abstract][Full Text] [Related]
8. Autoradiographical distribution of imidazoline binding sites in monoamine oxidase A deficient mice. Anderson NJ; Seif I; Nutt DJ; Hudson AL; Robinson ES J Neurochem; 2006 Mar; 96(6):1551-9. PubMed ID: 16476082 [TBL] [Abstract][Full Text] [Related]
10. Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes. Alemany R; Olmos G; García-Sevilla JA Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):39-47. PubMed ID: 9228188 [TBL] [Abstract][Full Text] [Related]
12. Stimulation of locus coeruleus neurons by non-I1/I2-type imidazoline receptors: an in vivo and in vitro electrophysiological study. Ugedo L; Pineda J; Ruiz-Ortega JA; Martín-Ruiz R Br J Pharmacol; 1998 Dec; 125(8):1685-94. PubMed ID: 9886760 [TBL] [Abstract][Full Text] [Related]
13. Chronic administration of 2-(2-benzofuranyl)-2-imidazoline (2-BFI) induces region-specific increases in [3H]2-BFI binding to rat central imidazoline I2 sites. MacInnes N; Handley SL Neurosci Lett; 2004 Jun; 363(1):11-3. PubMed ID: 15157985 [TBL] [Abstract][Full Text] [Related]
14. Relationship between imidazoline(2) sites and monoamine oxidase. Paterson LM; Tyacke RJ; Nutt DJ; Hudson AL Ann N Y Acad Sci; 2003 Dec; 1009():353-6. PubMed ID: 15028610 [TBL] [Abstract][Full Text] [Related]
15. Identification of imidazoline-receptor binding sites in cortex and medulla of the bovine adrenal gland. Colocalization with MAO-A and MAO-B. King PR; Gundlach AL; Louis WJ Ann N Y Acad Sci; 1999 Jun; 881():161-70. PubMed ID: 10415911 [TBL] [Abstract][Full Text] [Related]
16. I2-imidazoline binding sites: relationship with different monoamine oxidase domains and identification of histidine residues mediating ligand binding regulation by H+1. Limon-Boulez I; Tesson F; Gargalidis-Moudanos C; Parini A J Pharmacol Exp Ther; 1996 Feb; 276(2):359-64. PubMed ID: 8632297 [TBL] [Abstract][Full Text] [Related]
17. Effects of I Keller B; García-Sevilla JA Neurochem Int; 2017 Sep; 108():169-176. PubMed ID: 28342965 [TBL] [Abstract][Full Text] [Related]
18. Computational comparison of imidazoline association with the I2 binding site in human monoamine oxidases. Basile L; Pappalardo M; Guccione S; Milardi D; Ramsay RR J Chem Inf Model; 2014 Apr; 54(4):1200-7. PubMed ID: 24601544 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the binding of [3H]Ro 41-1049 to the active site of human monoamine oxidase-A. Cesura AM; Bös M; Galva MD; Imhof R; Da Prada M Mol Pharmacol; 1990 Mar; 37(3):358-66. PubMed ID: 2314388 [TBL] [Abstract][Full Text] [Related]
20. [3H]Rilmenidine-labelled imidazoline-receptor binding sites co-localize with [3H]2-(benzofuranyl)-2-imidazoline-labelled imidazoline-receptor binding sites and monoamine oxidase-B in rabbit, but not rat, kidney. King PR; Suzuki S; Hosseini AR; Iakovidis D; Nero TL; Jackman GP; Louis WJ; Gundlach AL J Auton Nerv Syst; 1998 Oct; 72(2-3):118-28. PubMed ID: 9851560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]